Loading...
MISX
RASP
Market cap1.02bUSD
Sep 17, Last price  
129.25RUB
1D
0.24%
1Q
-29.66%
Jan 2017
31.48%
IPO
66.38%
Name

Raspadskaya PAO

Chart & performance

D1W1MN
MISX:RASP chart
P/E
—
P/S
0.01
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
20.96%
Revenues
119.24b
-26.33%
19,263,315,59535,470,626,98414,978,064,00221,584,769,78223,227,056,10216,454,616,86517,935,744,94924,646,416,04530,786,188,41030,738,112,60050,057,672,84075,399,579,50061,748,295,00046,056,546,000156,450,420,000209,241,966,000185,823,000,000161,858,925,000119,238,000,000
Net income
-53.07b
L+329.67%
5,874,926,28215,684,592,5653,513,515,5237,487,122,7614,332,522,956000-9,257,899,14011,327,790,50018,396,771,47031,132,729,60012,895,226,00013,169,643,00064,412,966,00058,833,000,00034,620,000,000-12,350,681,000-53,067,000,000
CFO
18.88b
P
8,058,028,67417,293,805,9136,649,571,3109,418,937,1127,444,163,6623,373,177,3201,755,014,8107,242,238,0007,478,089,00010,519,698,00023,673,195,00024,947,266,00022,469,159,00013,560,922,00064,087,000,00066,398,000,00025,722,000,000-92,862,00018,879,000,000
Dividend
Jan 17, 202228 RUB/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing in the development of therapeutic solutions aimed at treating various forms of leukemia and lymphoma. Additionally, the company is engaged in formulating small molecule drug candidates, with a particular emphasis on addressing acute myeloid leukemia. Established in 2013, its corporate headquarters are situated in New York, NY.

Key people

Alexander Frolov
Non-Executive Chairman of the Board · since 2021
Ilya Shirokobrod
Chief Executive Officer, Member of the Executive Board · since 2022
Andrey Davydov
General Director of Raspadskaya Coal Company · since 2022
Olga Kuligina
Secretary to the Board of Director · since 2013
Aleksey Ivanov
Non-Executive Member of the Board of Director · since 2017
Nikolay Ivanov
Non-Executive Member of the Board of Director · since 2017
Marat Atnashev
Independent Member of the Board of Director · since 2021
Igor Bogachev
Independent Member of the Board of Director · since 2022
Olga Pokrovskaya
Independent Member of the Board of Director · since 2017
Erik Hugh Stoyell
Independent Member of the Board of Director · since 2021
Regina Von Flemming
Independent Member of the Board of Director · since 2022
URL
https://raspadskaya.com/
IPO date
Nov 10, 2006
Employees
Domiciled in
RU
Incorporated in
RU

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT